Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | MME | P08473 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | ESRRB | O95718 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.31 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16638169 | 0.88 | ZDHHC7 (0.42) | ZDHHC7SMN1; SMN2CA14MMECA1 | |
| SCHEMBL1415280 | 0.85 | ZDHHC7 (0.54) | ZDHHC7SMN1; SMN2CA14CA12MME | |
| SCHEMBL105448 | 0.85 | CA12 (0.38) | ZDHHC7SMN1; SMN2CA14CA12CA1 | |
| SCHEMBL12190597 | 0.85 | ZDHHC7 (0.40) | ZDHHC7SMN1; SMN2MMECA1CA2 | |
| SCHEMBL29038034 | 0.84 | ZDHHC7 (0.48) | ZDHHC7SMN1; SMN2CA14CA12MME | |
| SCHEMBL936362 | 0.84 | ZDHHC7 (0.48) | ZDHHC7SMN1; SMN2CA14CA12MME | |
| SCHEMBL6683720 | 0.84 | ZDHHC7 (0.48) | ZDHHC7SMN1; SMN2CA14CA12MME | |
| SCHEMBL24072865 | 0.83 | SMN1; SMN2 (0.46) | ZDHHC7SMN1; SMN2CA14CA12MME | |
| SCHEMBL1557617 | 0.83 | SMN1; SMN2 (0.46) | ZDHHC7SMN1; SMN2CA14CA12MME | |
| SCHEMBL13624472 | 0.82 | ZDHHC7 (0.49) | ZDHHC7SMN1; SMN2CA1CA2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120059173-A1 | DENDRITIC MOLECULES | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059173-A1 | DENDRITIC MOLECULES | CD40LG, CD40, TLR3 | ZDHHC7 1707/4885SMN1; SMN2 4881/4885CA14 2214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.